AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
AnGes Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2011 | 4.614M |
| September 30, 2011 | 4.908M |
| June 30, 2011 | 4.687M |
| March 31, 2011 | 4.413M |
| December 31, 2010 | 0.1353M |
| Date | Value |
|---|---|
| September 30, 2010 | 0.1276M |
| June 30, 2010 | 0.1275M |
| March 31, 2010 | 0.1276M |
| December 31, 2009 | 0.1254M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Takeda Pharmaceutical Co Ltd | -2.274B |
| Nxera Pharma Co Ltd | 344.46M |
| PeptiDream Inc | 1.883M |
| Stemcell Holdings Inc | -0.0934M |
| Healios KK | 23.78M |